IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Sfoglia per Rivista  UROLOGIC ONCOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 11 a 19 di 19
Titolo Data di pubblicazione Autore(i) File
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up 1-gen-2005 Berruti, Alfredo; Fara, E; Tucci, M; Tarabuzzi, R; Mosca, A; Terrone, C; Gorzegno, G; Fasolis, G; Tampellini, M; Porpiglia, F; DE STEFANIS, M; Fontana, D; Bertetto, O; Dogliotti, L.
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study. 1-gen-2012 A., Antonelli; N., Arrighi; S., Corti; T., Zanotelli; A., Cozzoli; S. C., Cunico; Simeone, Claudio
Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification 1-gen-2013 Abdollah, F; Sun, M; Suardi, N; Gallina, A; Capitanio, U; Bianchi, M; Tutolo, M; Fossati, N; Castiglione, F; Freschi, M; Karakiewicz, P; Rigatti, P; Montorsi, F; Briganti, A
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. 1-gen-2013 Saini, A; Berruti, Alfredo; Cracco, C; Sguazzotti, E; Porpiglia, F; Russo, L; Bertaglia, V; Picci, Rl; Negro, M; Tosco, A; Campagna, S; Scarpa, Rm; Dogliotti, L; Furlan, Pm; Ostacoli, L.
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 1-gen-2013 Vigna-Taglianti, R; Russi, Eg; Boriano, A; Gianello, L; Denaro, N; Lucio, F; Arena, G; e Bastia M, Buglione Di Monale; Pergolizzi, S; Ricardi, U; Magrini, S.
The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: Conditional survival analysis 1-gen-2014 Abdollah, F; Suardi, N; Capitanio, U; Matloob, R; Fossati, N; Castiglione, F; Di Trapani, E; Di Trapani, D; Russo, A; Carenzi, C; Montorsi, F; Rigatti, P; Bertini, R
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset 1-gen-2020 Veccia, A.; Antonelli, A.; Minervini, A.; Mottrie, A.; Dell'Oglio, P.; Ashrafi, A. N.; Larcher, A.; Eun, D.; Bradshaw, A.; Amparore, D.; Brassetti, A.; Hampton, L. J.; Simeone, C.; Mari, A.; Carini, M.; De Naeyer, G.; Yang, K.; Capitanio, U.; Simone, G.; Porpiglia, F.; Derweesh, I.; Aron, M.; Autorino, R.
Utility of [C-11]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series 1-gen-2014 Passoni, Nm; Suardi, N; Abdollah, F; Picchio, M; Giovacchini, G; Messa, C; Freschi, M; Montorsi, F; Briganti, A
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series 1-gen-2015 Gandaglia, G; Ploussard, G; Isbarn, H; Suardi, N; De Visschere, Pjl; Futterer, Jj; Ghadjar, P; Massard, C; Ost, P; Sooriakumaran, P; Surcel, Ci; van den Bergh, Rcn; Montorsi, F; Ficarra, V; Giannarini, G; Briganti, A
Mostrati risultati da 11 a 19 di 19
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile